EUVIMEDEUVIMED entdecken
Crossref

Quercetin targets Serpine1 to inhibit angiogenesis and suppress gastric cancer progression

Jinduo Pan, Peng Wu, Shuang Yang, Shengjia Liang, Limin Cao, Xingguo Liu

Molecular Immunology · 2026-09 · 197 · 76-88

DOI: 10.1016/j.molimm.2026.07.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Immunology, 2026-09. Verfasst von Jinduo Pan und 5 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery, Affiliated Jiangmen Traditional Chinese Medicine Hospital of Jinan University, Jiangmen, Guangdong 529000, China. Hauptthemen laut MEDLINE: Quercetin, Stomach Neoplasms, Plasminogen Activator Inhibitor 1, Neovascularization, Pathologic. Die Arbeit nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Gastric cancer (GC) is one of the most common malignancies, characterized by high mortality and recurrence rates. Quercetin, a natural flavonoid found in various herbs and foods, exhibits potential therapeutic effects against GC. This study aims to explore the potential molecular mechanisms of quercetin in the treatment of GC. METHODS: Bioinformatic analyses were performed using the TCGA-STAD dataset to evaluate SERPINE1 expression, prognosis, angiogenesis-related pathway enrichment, and correlations with angiogenic factors. Molecular docking was employed to predict the binding affinity between quercetin and Serpine1, followed by validation using cellular thermal shift assay (CETSA). Cell proliferation and cytotoxicity were assessed by CCK-8 assays in GC cells and normal gastric epithelial GES-1 cells, and IC50 values were calculated. Serpine1 overexpression and siRNA-mediated knockdown were performed to investigate its functional role. Colony formation assays were used to evaluate clonogenic ability, apoptosis was analyzed by flow cytometry, and Transwell and wound healing assays were used to assess invasion and migration. Tube formation assays were conducted to examine angiogenic potential in HUVECs. Western blotting and qPCR were used to detect Serpine1, angiogenesis-related genes (VEGFA, FGF-2, FGF-7), and HUVEC angiogenesis markers (VEGFR-2, CD31, VE-cadherin). VEGFA secretion in cell supernatants was quantified by ELISA. RESULTS: Bioinformatic analysis showed that Serpine1 was highly expressed in GC tissues, associated with poor prognosis, and positively correlated with angiogenesis-related signatures and factors, including VEGFA, FGF-2, and FGF-7. Quercetin suppressed proliferation, invasion, and migration while promoting apoptosis in GC cells. At the selected treatment concentration, quercetin showed stronger inhibitory effects on GC cells than on GES-1 cells. Serpine1 expression was upregulated in GC cells and downregulated after quercetin treatment. Serpine1 knockdown inhibited GC cell proliferation, colony formation, migration, invasion, and angiogenic potential, while promoting apoptosis. Conversely, Serpine1 overexpression enhanced GC proliferation, invasion, and migration and inhibited apoptosis, whereas quercetin counteracted these effects. Quercetin also reduced angiogenesis-related factors (VEGFA, FGF-2, and FGF-7) in GC cells and decreased HUVEC angiogenesis-associated proteins (VEGFR-2, CD31, and VE-cadherin). These findings suggest that the anti-GC and anti-angiogenic effects of quercetin are mediated, at least in part, through targeting Serpine1. CONCLUSION: Our experimental results demonstrate that quercetin inhibits GC progression by targeting Serpine1 to suppress angiogenesis in vitro. Serpine1 represents a potential therapeutic target for GC treatment with quercetin, providing a new research direction for future treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinStomach NeoplasmsPlasminogen Activator Inhibitor 1Neovascularization, PathologicHumansCell ProliferationCell Line, TumorCell MovementDisease ProgressionApoptosisHuman Umbilical Vein Endothelial CellsMolecular Docking SimulationGene Expression Regulation, NeoplasticAngiogenesis Inhibitors

Stichwörter der Autor:innen

AngiogenesisGastric cancerQuercetinSerpine1

Substanzen

QuercetinPlasminogen Activator Inhibitor 1SERPINE1 protein, humanAngiogenesis Inhibitors

Autor:innen und Institutionen

  • General Surgery, Affiliated Jiangmen Traditional Chinese Medicine Hospital of Jinan University, Jiangmen, Guangdong 529000, China.
  • General Surgery, Affiliated Jiangmen Traditional Chinese Medicine Hospital of Jinan University, Jiangmen, Guangdong 529000, China. Electronic address: pjd19860719@163.com.

Zitieren

APA

Pan, J., Wu, P., Yang, S., Liang, S., Cao, L., & Liu, X. (2026). Quercetin targets Serpine1 to inhibit angiogenesis and suppress gastric cancer progression. Molecular Immunology, 197, 76-88. https://doi.org/10.1016/j.molimm.2026.07.006

Vancouver

Pan J, Wu P, Yang S, Liang S, Cao L, Liu X. Quercetin targets Serpine1 to inhibit angiogenesis and suppress gastric cancer progression. Molecular Immunology. 2026;197:76-88. doi:10.1016/j.molimm.2026.07.006

BibTeX
@article{Pan2026,
  author = {Pan, Jinduo and Wu, Peng and Yang, Shuang and Liang, Shengjia and Cao, Limin and Liu, Xingguo},
  title = {Quercetin targets Serpine1 to inhibit angiogenesis and suppress gastric cancer progression},
  journal = {Molecular Immunology},
  year = {2026},
  volume = {197},
  pages = {76--88},
  doi = {10.1016/j.molimm.2026.07.006}
}
Kostenlos starten →